Free Trial

Accelerate Diagnostics (AXDX) Earnings Date, Estimates & Call Transcripts

Accelerate Diagnostics logo
$0.04 +0.04 (+∞)
As of 05/14/2025
This is a fair market value price provided by Polygon.io. Learn more.

Accelerate Diagnostics Earnings Summary

Accelerate Diagnostics announced Q4 2024 earnings on March 20, 2025, reporting an EPS of -$0.37, which beat analysts' consensus estimates of -$0.50 by $0.13. Quarterly revenue was reported to be $2.82 million, below the consensus estimate of $3 million. With a trailing EPS of -$2.34, Accelerate Diagnostics' earnings are expected to grow next year, from ($2.30) to ($2.00) per share.

Latest Q4
Earnings Date
Mar. 20Estimated
Consensus EPS
(Mar. 20)
-$0.50
Actual EPS
(Mar. 20)
-$0.37 Beat By $0.13
Actual Revenue
(Mar. 20)
$2.82M

Q4 2024 Earnings Resources

Get Accelerate Diagnostics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Accelerate Diagnostics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

AXDX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AXDX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Accelerate Diagnostics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.49-$0.49-$0.49
Q2 20251-$0.49-$0.49-$0.49
Q3 20251-$0.50-$0.50-$0.50
Q4 20251-$0.52-$0.52-$0.52

Accelerate Diagnostics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/20/2025Q4 2024-$0.50-$0.37+$0.13-$0.37$3.00M$2.82M
8/8/2024Q2 2024-$0.55-$0.50+$0.05-$0.50$3.00M$2.99M
5/8/2024Q1 2024-$0.72-$0.88 -$0.16-$0.88$3.00M$2.92M
3/28/2024Q4 2023-$0.62-$0.89 -$0.27-$0.89$3.80M$3.03M
11/9/2023Q3 2023-$0.94-$0.92+$0.02-$1.90$3.60M$3.30M
8/10/2023Q2 2023-$1.50-$2.36 -$0.86-$2.36$4.00M$2.92M

Accelerate Diagnostics Earnings - Frequently Asked Questions

Accelerate Diagnostics (NASDAQ:AXDX) last announced its quarterly earning data on Thursday, March 20, 2025. Learn more on AXDX's earnings history.

In the previous quarter, Accelerate Diagnostics (NASDAQ:AXDX) reported ($0.37) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.50) by $0.13. Learn more on analysts' earnings estimate vs. AXDX's actual earnings.

Accelerate Diagnostics (NASDAQ:AXDX) has a recorded annual revenue of $11.70 million.

Accelerate Diagnostics (NASDAQ:AXDX) has a recorded net income of -$61.62 million. AXDX has generated -$2.34 earnings per share over the last four quarters.

Accelerate Diagnostics's earnings are expected to grow from ($2.30) per share to ($2.00) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:AXDX) was last updated on 6/2/2025 by MarketBeat.com Staff
From Our Partners